Park Avenue Securities’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.01M | Buy |
+27,239
| New | +$7.54M | 0.04% | 343 |
|
|
2026
Q1 | – | Sell |
-36,379
| Closed | -$9.93M | – | 1546 |
|
|
2025
Q4 | $9.93M | Buy |
36,379
+7,545
| +26% | +$2.05M | 0.08% | 188 |
|
|
2025
Q3 | $7.79M | Buy |
28,834
+7,005
| +32% | +$1.91M | 0.06% | 238 |
|
|
2025
Q2 | $6.02M | Buy |
21,829
+8,355
| +62% | +$2.27M | 0.06% | 244 |
|
|
2025
Q1 | $3.57M | Buy |
13,474
+108
| +0.8% | +$26.6K | 0.04% | 263 |
|
|
2024
Q4 | $3.1M | Buy |
13,366
+968
| +8% | +$223K | 0.03% | 337 |
|
|
2024
Q3 | $2.74M | Sell |
12,398
-1,031
| -8% | -$213K | 0.03% | 349 |
|
|
2024
Q2 | $2.64M | Sell |
13,429
-951
| -7% | -$196K | 0.03% | 337 |
|
|
2024
Q1 | $3.1M | Buy |
14,380
+392
| +3% | +$82.3K | 0.04% | 286 |
|
|
2023
Q4 | $2.95M | Buy |
13,988
+566
| +4% | +$121K | 0.04% | 269 |
|
|
2023
Q3 | $2.69M | Sell |
13,422
-188
| -1% | -$37.4K | 0.04% | 259 |
|
|
2023
Q2 | $2.52M | Sell |
13,610
-32
| -0.2% | -$5.91K | 0.04% | 267 |
|
|
2023
Q1 | $2.61M | Sell |
13,642
-960
| -7% | -$174K | 0.04% | 243 |
|
|
2022
Q4 | $2.46M | Sell |
14,602
-468
| -3% | -$81.3K | 0.04% | 252 |
|
|
2022
Q3 | $2.67M | Buy |
15,070
+476
| +3% | +$94.1K | 0.05% | 209 |
|
|
2022
Q2 | $2.99M | Buy |
14,594
+44
| +0.3% | +$9.33K | 0.06% | 196 |
|
|
2022
Q1 | $3.46M | Buy |
14,550
+501
| +4% | +$118K | 0.06% | 177 |
|
|
2021
Q4 | $3.21M | Buy |
14,049
+604
| +4% | +$133K | 0.06% | 196 |
|
|
2021
Q3 | $2.6M | Sell |
13,445
-525
| -4% | -$106K | 0.05% | 196 |
|
|
2021
Q2 | $2.97M | Buy |
13,970
+577
| +4% | +$122K | 0.06% | 166 |
|
|
2021
Q1 | $2.73M | Buy |
13,393
+2,129
| +19% | +$419K | 0.07% | 150 |
|
|
2020
Q4 | $2.05M | Sell |
11,264
-771
| -6% | -$131K | 0.06% | 152 |
|
|
2020
Q3 | $2.01M | Buy |
12,035
+988
| +9% | +$166K | 0.07% | 133 |
|
|
2020
Q2 | $1.8M | Buy |
11,047
+1,934
| +21% | +$347K | 0.07% | 130 |
|
|
2020
Q1 | $1.58M | Sell |
9,113
-54
| -0.6% | -$10.7K | 0.13% | 62 |
|
|
2019
Q4 | $1.84M | Buy |
9,167
+320
| +4% | +$65.6K | 0.08% | 109 |
|
|
2019
Q3 | $1.87M | Buy |
8,847
+737
| +9% | +$154K | 0.09% | 92 |
|
|
2019
Q2 | $1.57M | Sell |
8,110
-248
| -3% | -$45.7K | 0.18% | 49 |
|
|
2019
Q1 | $1.39M | Buy |
8,358
+1,792
| +27% | +$317K | 0.08% | 92 |
|
|
2018
Q4 | $1.19M | Buy |
6,566
+1,069
| +19% | +$197K | 0.18% | 41 |
|
|
2018
Q3 | $958K | Buy |
5,497
+1,288
| +31% | +$217K | 0.15% | 45 |
|
|
2018
Q2 | $690K | Buy |
4,209
+827
| +24% | +$135K | 0.12% | 55 |
|
|
2018
Q1 | $533K | Buy |
3,382
+669
| +25% | +$106K | 0.12% | 65 |
|
|
2017
Q4 | $393K | Buy |
2,713
+313
| +13% | +$44.6K | 0.1% | 63 |
|
|
2017
Q3 | $327K | Buy |
2,400
+353
| +17% | +$44.6K | 0.1% | 62 |
|
|
2017
Q2 | $259K | Buy |
2,047
+262
| +15% | +$31.3K | 0.03% | 159 |
|
|
2017
Q1 | $210K | Buy |
+1,785
| New | +$215K | 0.09% | 44 |
|
Other funds holding CME
PAM
SP
RG
HCM
CF
OIAM
SI
Park Avenue Securities's CME Position: Q2 2026 in Review
Park Avenue Securities opened a new position in CME Group (CME) in Q2 2026: 27,239 shares worth $6.01M. The stake represents 0.04% of the portfolio and ranks #343 among its holdings. This is a return to the name: Park Avenue Securities previously reported a position in CME as recently as Q4 2025.
Park Avenue Securities first reported a position in CME in Q1 2017 and has held it in 37 quarters since. The position peaked at $9.93M in Q4 2025. 439 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Park Avenue Securities held 27,239 shares of CME Group worth $6.01M as of Q2 2026.
- CME Group was a new Park Avenue Securities position in Q2 2026.
- CME Group made up 0.04% of Park Avenue Securities's portfolio in Q2 2026, its #343 holding.
- Park Avenue Securities first reported a position in CME Group in Q1 2017 and has held it in 37 quarters since.
- Park Avenue Securities's CME Group position peaked at $9.93M in Q4 2025.
- 439 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.